Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Lisata Therapeutics News

prnewswire.com

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
2 days ago
prnewswire.com

SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30

6 days ago
prnewswire.com

Keymed Biosciences annonce les derniers rsultats d'un essai clinique valuant CM336 publis dans le New England Journal of Medicine

7 days ago
prnewswire.com

Keymed Biosciences gibt die neuesten Ergebnisse der klinischen Studie mit CM336 bekannt, die im New England Journal of Medicine verffentlicht wurden

8 days ago
prnewswire.com

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

9 days ago
prnewswire.com

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

10 days ago
prnewswire.com

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

Feature Image for interests on Biotechnology, Contracts, Health Care & Hospitals, Healthcare from prnewswire.com
10 days ago
prnewswire.com

Alamar Biosciences, die Alzheimer's Disease Data Initiative und Gates Ventures schlieen sich zu einer globalen Partnerschaft zusammen, um die translationale Forschung auf dem Gebiet der Alzheimer-Krankheit voranzutreiben.

Feature Image for interests on Biotechnology, Computer & Electronics, Health Care & Hospitals, Healthcare from prnewswire.com
11 days ago
prnewswire.com

Alamar Biosciences, l'Alzheimer's Disease Data Initiative et Gates Ventures unissent leurs forces dans un partenariat mondial pour faire progresser la recherche translationnelle sur la maladie d'Alzheimer

Feature Image for interests on Biotechnology, Computer & Electronics, Health Care & Hospitals, Healthcare from prnewswire.com
12 days ago
prnewswire.com

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.

Feature Image for interests on Biotechnology, Computer & Electronics, Healthcare, Stock from prnewswire.com
12 days ago
Stocks
Health Care
lsta
Lisata Therapeutics
LSTA
+0.11 (+4.73%)
2.545
USD
At close at Jun 20, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Lisata Therapeutics: SciBase and Castle Biosciences Partner to Transform Atopic Dermatitis Management

3 days ago
publisher logo
Cashu

Lisata Therapeutics Explores Bispecific Antibody Advances in Autoimmune Hemolytic Anemia Treatment

6 days ago
publisher logo
Cashu

Lisata Therapeutics Explores Innovations in Autoimmune Hemolytic Anemia with Keymed's CM336 Breakthrough

7 days ago